Pharmacokinetic and PHarmacodynamic Analysis and Evaluation of Teriparatide (PTH 1-34) Between Sexes

NCT04921124 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Stress Fracture

Interventions

DRUG: Teriparatide

Sponsor

Norfolk and Norwich University Hospitals NHS Foundation Trust

Collaborators

[object Object]
[object Object]